Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Go back to Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: TENX) Delayed: 12.25 +0.25 (2.08%)
Previous Close $12.00    52 Week High $3.40 
Open $12.50    52 Week Low $1.34 
Day High $12.70    P/E N/A 
Day Low $11.86    EPS $0.00 
Volume 869,727